#Infertility in Amreli

[snehhospital]

Women's Hospital in Amreli | Gynecologist in Amreli - Sneh Hospital

Women's Hospital in Amreli - Sneh Hospital's Amreli Branch - is the best Gynecologist, Infertility, IVF & Maternity clinic in Rajkot, Gujarat. Book an Appointment! Gynecologist in Amreli.

Women's Hospital in Amreli, Women's Hospital in Amreli Rajkot, Gynecologist in Amreli, Gynecologist in Amreli Rajkot, Best Gynecologist, Infertility in Amreli, Infertility in Amreli, Maternity Hospital in Amreli, IVF Center in Amreli, www.snehhospitals.com/gujarat/amreli/, Sneh Hospital

[atlanticcanada]

'Highly resistant' gonorrhea on the rise in Canada, other countries: World Health Organization

Several countries, including Canada, are seeing a spike in cases of gonorrhea that are “highly resistant” to existing treatments, according to the World Health Organization’s most recent guidance regarding sexually transmitted infections.

The World Health Organization (WHO) shared the warning in a news release Monday regarding their latest guidelines for testing for and diagnosing sexually transmitted infections (STIs).

According to the organization, the COVID-19 pandemic caused disruptions to prevention, testing and treatment services for STIs in many countries, leaving them battling a new resurgence of these infections now – and the spectre of antimicrobial resistance is making these infections harder to kick than ever.

“Of concern, the spread of a Neisseria gonorrhea clone that is highly resistant to ceftriaxone is increasingly being reported in countries in Asia such as China, Japan, Singapore and Vietnam as well as in Australia, Austria, Canada, Denmark, France, Ireland and the United Kingdom,” the release stated.

“The enhanced gonorrhea AMR surveillance (EGASP) suggests high rates of resistance in gonorrheae to current treatment options such as ceftriaxone, cefixime and azithromycin in Cambodia, for instance.”

Gonorrhea is an STI that is caused by infection with the Neisseria gonorrheae bacterium, which infects the mucus membranes of the reproductive tract, or of the mouth, throat, eyes or rectum. It is transmitted by sexual contact with the genitals, mouth or anus of an infected partner, or can be spread from an infected mother to their baby during childbirth.

In 2020, WHO estimates that 82 million new infections of gonorrhea occurred worldwide, making it the third most common STI in terms of new infections after trichomoniasis and chlamydia.

According to Statistics Canada, gonorrhea cases in Canada have almost tripled over the past decade, with more than 35,000 cases reported in 2019. Two-thirds of these cases were among men, and more than half were among people less than 30 years of age.

If it goes untreated, gonorrhea can spread to the uterus or fallopian tubes and cause pelvic inflammatory disease, which can include severe abdominal pain and fever and may lead to chronic pelvic pain or even infertility. It can also cause infertility in men in rare cases, according to the U.S. Centres for Disease Control and Prevention, and can increase the risk of a person transmitting or acquiring HIV.

Another uncommon, but severe complication that can arise from gonorrhea going untreated is the infection spreading to the blood and causing a condition called disseminated gonococcal infection (DGI), which can be life-threatening.

There are more than one million STIs acquired every day across the globe, according to WHO, with most of them having no obvious symptoms.

Gonorrhea is one of four common STIs that are considered curable, a list which also includes syphilis, chlamydia and trichomoniasis.

However, increasing antimicrobial resistance is cutting into the effectiveness of treatments for gonorrhea, according to WHO.

Antimicrobial resistance (AMR) is when bacteria, viruses and parasites change to evade medicines, making antimicrobial medications ineffective over time.

“With resistance to both cephalosporins, including third-generation extended spectrum cephalosporins, and fluoroquinolones, N. gonorrheae is a multidrug-resistant pathogen,” a report released with the guidelines states. “Resistance is outpacing new antibiotics for N. gonorrheae.”

The organization stated that the bacterium behind gonorrhea is a “priority microorganism for AMR monitoring in the Global Antimicrobial Surveillance System” and that they are looking to spur development for new drugs to tackle gonorrhea.

“New models of STIs services need to be resilient and adaptive to current and future threats,” Dr. Meg Doherty, Director of WHO’s Global HIV, Hepatitis and Sexually Transmitted Infections Programmes, said in the release. “Recent scientific advances in STIs treatment and technologies, and innovative service delivery methods, provide an important opportunity to end STIs as a public health concern by 2030. However, large variations in investment, maturity and performance of STI surveillance systems between countries continues to be a challenge”.

According to WHO, gonorrhea isn’t the only STI that is currently posing a difficulty in terms of treatment.

“Syphilis, as well as congenital syphilis, are on the rise, and the lack of benzathine penicillin poses a considerable challenge to effectively treat them,” the release stated.

WHO’s new guidance includes descriptions of what point-of-care tests for syphilis, gonorrhea, chlamydia and trichomonas vaginalis should look like in order to “facilitate development of quality STI diagnostics.”

Point-of-care testing, in general, refers to tests that are performed at or near a patient and at the site where treatment or care is provided. It encompasses tests that can be done simply and provide results relatively quickly, including tests that can be performed by a patient themselves, as opposed to tests that may require highly specialized locations and extended processing at a lab.

“Early testing and diagnosis are key in stopping the spread of STIs. When left untreated, certain STIs can lead to long-term irreversible outcomes and some can be potentially fatal, “Dr. Teodora Wi, Lead for Sexually transmitted infections of the WHO Global HIV, Hepatitis and STIs Programmes, said in the release. “Our new guidance can help make low-cost point of care tests for STIs more accessible, enabling improved data collection and quality delivery of STI services for people in need.”

Gonorrhea often has no symptoms at all, making the implementation of screening and simple tests even more important, experts say.

When there are symptoms, urethral infection in men may include a white, yellow or green discharge appearing one to fourteen days after infection. If the infection is complicated by epididymitis, men may experience testicular pain as well. Symptoms in women are so subtle that they are often mistaken for a bladder or vaginal infection, sure as vaginal discharge or vaginal bleeding between periods.

Rectal infection in all persons can include symptoms of discharge, itching, soreness, bleeding or painful bowel movements, but it can also be asymptomatic.

You can minimize your chances of contracting gonorrhoea by using condoms during sexual activities and limiting your sexual partners, as well as ensuring you get tested regularly. 

The World Health Organization (WHO) is currently sharing its latest guidance on testing for and diagnosing sexually transmitted infections at the STI & HIV 2023 World Congress in Chicago, U.S., which runs from Monday to Thursday. 

from CTV News - Atlantic https://ift.tt/XBraqli

[bintadnan]

Live for Allah

“I want to be of those who are close to Allah.” Imagine being like Ibn Taymiyyah, who stated, “What can my enemies do to me? I have in my breast both my heaven and my garden. If I travel they are with me, never leaving me. Imprisonment for me is a chance to be alone with my Lord. To be killed is martyrdom and to be exiled from my land is a spiritual journey.”

We need to have high aspirations, and we need to have the desire to be someone special to Allah. Once Allah becomes our main concern, we can insha'Allah be in the same mindset as Ibn Taymiyyah. What can people do to us when we carry paradise in our hearts?

One of the Names of Allah that should inspire us is Al-Wali, The Ally. Allah says in the Qur’an:

“Allah is the ally [Wali] of those who believe. He brings them out from darkness into the light…” (Qur’an, 2:257)

What do you feel when you read this verse? Many of us have read this verse again and again, and some of us have contemplated over the meaning of being a wali of Allah. Whenever we think of someone being a wali of Allah, we think of great devoted scholars, courageous fighters, people truly close to Allah… but not us. “We could never be His awliya… could we?”

Allah tells us in this verse that He is the Wali of those who believe. As believers, we are already part of that group, insha’Allah. But to truly earn the status of Allah’s Wali, to be at that elevated level, we have to aspire towards it.

What does Al-Wali mean?

Al-Wali has different translations; the ‘ally’, ‘protector’, ‘guardian’ or ‘patron’. In Arab countries, schools usually request the permission of “wali amr” (the Wali of the affairs) of a child for anything concerning him or her, meaning the child’s guardian. What are the characteristics of a child’s guardian?

It must be a person who a) is close to the child, and b) takes care of the child.

If Allah is your Wali, then He is close to you and takes care of you.

Allah took care of the affairs of the Prophet Yusuf `alayhi sallatu wa sallam (may Allah send His peace and blessings on him). When Yusuf (as) was alone in the well, Allah made specific travellers thirsty at that particular time so that they could rescue him and take him on their journey with them. Later, the people who bought Yusuf (as) as a slave turned out to be a couple who were infertile. At every step of the way, Allah was with Yusuf (as). No doubt, he faced hardships, but Allah is always protecting.

So, there are going to be problems even if you are a Wali of Allah, but at the end of the day, He is still taking care of you. At the end of Yusuf’s (as) story, he proclaims, “Creator of the heavens and earth, You are my Wali in this world and in the Hereafter.” (Quran, 12:101).

Truly, it is an impoverished person who does not have Allah as their Wali, the person who takes his Wali as the dunya.

-Jinan Yousef

[swamp-bumpkin]

Spicy lore left out of Fate

so one of the spicier bits of lore that’s often left out of the fate series is the fact that King Arthur had other kids (just not by Guinevere, one of the rumors about her in the original legends was that she was infertile). Probably would have fucked her up a bit though due to all of them dying young (in which case Mordred calling themselves Arturia’s only son/heir would have been like dumping a huge pile of salt in a particularly nasty wound). So here are the other sons and their deaths

Amr: Killed by Arthur, circumstances unknown

Gwydre: Killed by the Twrch Trwyrth

Llacheu: Was slain, slayer unknown, circumstances unknown

Duran: Died at the battle of Camlann

Lohot: Died of illness (in a poem Perlesvaus he actually is Guinevere’s child, however in that poem he is killed by Sir Kay)

[wenickjones]

IVF Services Market: Industry Size, Share, Trends, Key Players and Forecast by 2026

Facto Market Insights (FMI) is one of the leading market research analyst incorporated its latest research subject title “IVF SERVICES MARKET – 2020 – 2026 to its diverse bouquet of market research reports. With in depth study it provides bulls eye analysis of market drivers, its challenges, opportunity trends along with various key analytical insights. In addition FMI anticipates the report on global IVF services market to help its patrons to understand and gaze the important aspects that are expected to intensify the growth patterns of the global market in near future. The study and research doesn’t confine itself to just the patterns but takes a leap ahead and do a complete analysis of the market size and forecast for the different segments & geographies covering the impact analysis of ongoing covid 19 pandemic.

Get Free Sample Report at https://www.factomarketinsights.com/sample/283

The report on global IVF services market covers the key market growth indicators, covering the value and supply chain analysis, year-on-year (Y-o-Y) growth and compounded annual growth rate (CAGR), in the Facto Market Insights (FMI) research report along with top macroeconomic indicators. The study is way beneficial for the investors, manufacturers, suppliers, stakeholders, and distributors, because it can help them to understand the strategies of the market and also, they can withdraw information &statistics presented in market research report.

Impact Analysis of Coronavirus Disease (COVID-19)

The research report covers the impact analysis of COVID-19 pandemic on the global IVF services market, covering information about each region & countries in order to identify the issues raised by the pandemic over various industries. The outbreak of coronavirus or COVID-19 (formerly 2020-nCoV) was noted in December 2019, which has been imposed as a medical emergency across the globe. More than 213 countries and territories have reported cases of coronavirus till date. On 11th March 2020, the World Health Organization (WHO) declared the COVID-19 a pandemic officially. Countries including U.S., India, Italy, Germany, Spain, France, Brazil, and such other countries have a large number of COVID-19 patients, due to which the countries went under lockdown conditions in the past. Thus, with the ongoing situation of lockdown, many industries have been adversely impacted, and it is expected that the economy of such nations are going to suffer a massive loss over the upcoming years, and also the global economy is anticipated to slip into a recession, which is considered to hamper the growth of the overall market.

For Full Report with TOC Visit at https://www.factomarketinsights.com/report/283/ivf-services-market-amr

Segment Information  

The market for global IVF services market is segmented as Product Type, Form Type, Drug Type, End User and Region.

KEY MARKET SEGMENTS By Cycle Type • Fresh IVF Cycles (Non-Donor) • Thawed IVF Cycles (Non-Donor) • Donor Egg IVF Cycles

By End User • Fertility Clinics • Hospitals • Surgical centers • Clinical research institutes

Regional Representation

The market for IVF services is segregated on the basis of regional basis into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The breakdown of the region into countries is covered in the study. The study also includes the estimations about market growth at the regional and country levels. Further, the regions are fragmented into the country and regional groupings:

- North America (U.S. & Canada)

- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)

- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)

- Latin America (Brazil, Mexico and Rest of Latin America)

- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Competitive Landscape:

The report profiles various major & prominent key market players in the global IVF services market including:-

Ambroise Paré Group • amedes MVZ Cologne GmbH • AMP Center St Roch • AVA Clinic Scanfert • Bangkok IVF center • Bangkok IVF center (Bangkok Hospital) • Betamedics • Biofertility Center • Bloom Fertility and Healthcare • Bloom Fertility Center • Bourn Hall Fertility Center • Bourn Hall International • Cardone Reproductive Medicine and Infertility, LLC • Center for Advanced Reproductive Medicine and Infertility • CHA Fertility Center • Chelsea and Westminster Hospital (Assisted Conception Unit) • Cloudnine Fertility • Conceptions Reproductive Associates of Colorado • Cyprus IVF Centre • Dansk Fertilitetsklinik • EUVITRO S.L.U. • Fakih IVF Fertility Center • Fertility and Gynecology Center Monterey Bay IVF • Fertility Associates • Fertility Center Berlin • Fertility Center of San Antoni • Fertility First • FIV Marbella • Fivet Centers Prof. Zech • Flinders Reproductive Medicine Pty Ltd • Genea Oxford Fertility Limited • Heidelberg University Hospital • Houston Fertility Center • International Centre for Reproductive Medicine, ICRM • IVF Canada • IVF NAMBA Clinic • IVF Panama Center for Reproduction Punta Pacífica • IVF Spain • IVI Panama • Ivinsemer • KL Fertility & Gynaecology Centre • Lifesure Fertility and Gynaecology centre • LIV Fertility Center • Manipal Fertility • Maria Fertility Hospital • MD Medical Group • Medfem Fertility Clinic • Monash IVF Wesley Hospital Auchenflower • Morpheus Life Sciences Pvt. Ltd. • New hope fertility center • Oak Medical Group/Oak Clinic • OVA IVF Clinic Zurich • Procrea Fertility • RAPRUI Srl • Repromed • SAFE Fertility Center • Sanno Hospital • Servy Massey Fertility Institute • Shanghai Ji Ai Genetics & IVF Institute • Shanghai United Family Hospital • Sher Institute for Reproductive Medicine (SIRM) • Southend Fertility and IVF • StorkKlinik (Stork IVF Clinic) • The ARC-STER Center • The Bridge Centre • The Cape Fertility Clinic • The Hugh Wynter Fertility Management Unit • The Lister Fertility Clinic • The Montreal Fertility Center • Thomson Medical Pte. Ltd. • Trianglen Fertility Clinic • TRIO Fertility • Virtus Health • Vitanova • VivaNeo - Medical Center Kinderwens • Wunschkinder

For any Inquiry before buying this report visit at https://www.factomarketinsights.com/enquiry/283

About Us:

Facto Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.

Our in-house research experts have a wealth of knowledge in their respective domains. With Facto Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.

Our clients list includes various Fortune 500 companies and leading advisory firms.

Contact Us:

Facto Market Insights

90 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email:info@factomarketinsights.com

Website: www.factomarketinsights.com

[ivftreatmentinahmedabad]

Best Women's Hospital in Prahladnagar, Satellite

How to Find The Best Women’s Hospital in Satellite, Prahladnagar, Anandnagar, Vastrapur, Ahmedabad?

Sneh Women’s Hospital provides for Infertility, IVF Treatment, Maternity, Test tube baby, Gynaec & obstetric Sonography in your nearest Place Satellite, Prahladnagar, Anandnagar, Vastrapur, Shyamal, Ahmedabad, Surat Vadodara, Gujarat, Rajasthan. We are pioneers in Women’s fertility and IVF treatments. Sneh Hospital is the Best Women’s Hospital in Gujarat. That understands women’s high-risk pregnancy problems and understanding of how advanced health care can improve the lives of women.

One of the most Well-known, Famed Hospital which is well-accepted for Infertility and IVF treatment.

We are treating patients from all parts of Gujarat, Rajasthan nearest City: satellite, Vastrapur, prahaladnagar, surat, ahmedabad, baroda, gujarat, rajasthan, anand, bharuch, dahod, vapi, palanpur, mehsana, patan, himmatnagar, rajkot, jamnagar, morbi, amreli, bhavnagar, bhuj, jodhpur, dungarpur, banswara, alwarkadi, kalo, petlad, shirohi, surendra nagar. Couples are coming in from different parts of India, mainly Gujarat Rajasthan for all types of Infertility treatments to Women’s Hospital.

Sneh Hospital - Top Women's Hospital in Your Nearest Place

Women are most fertile and the chance of getting pregnant in 20 of age. This is the time when you the best reproductive year and your pregnancy risks are lowest. Fertility begins to declines at around age 32 and after 35 that declined fast. There’s a steep decline in a woman’s ability to get pregnant at 40 of age. But in IVF Treatment, There is no age bar. If you are living in Anand Nagar, Shyamal or Satellite. You must visit Sneh Hospital at Prahladnagar. It is better to find a hospital in nearby areas.

Meet Gynec Doctor Near Me

Sneh Hospital is one of the Best Gynecologist Hospital in Ahmedabad. Dr. Nisarg Dharaiya is the best Gynec Doctor Near Me. We offer Ivf treatment, maternity, pregnancy care to gynecology related issues and best treatment.

Read More: http://www.snehhospitals.com/best-womens-hospital-near-me.php

Best ivf hospital in satellite, best ivf hospital in prahladnagar, best ivf hospital in vastrapur, best ivf hospital in ahmedabad, best ivf clinic in satellite, best ivf clinic in prahladnagar, best ivf clinic in vastrapur, best ivf clinic in ahmedabad, best ivf doctor in satellite, best ivf doctor in prahlad nagar, best ivf doctor in vastrapur, best ivf doctor in ahmedabad, best ivf specialist in satellite, best ivf specialist in prahladnagar, best ivf specialist in vastrapur, best ivf specialist in ahmedabad, best test tube baby hospital in satellite.

Best test tube baby hospital in prahladnagar, best test tube baby hospital in vastrapur, best test tube baby hospital in ahmedabad, best gynaec hospital in satellite, best gynaec hospital in prahladnagar, best gynaec hospital in vastrapur, best gynaec hospital in ahmedabad, best surrogacy treatment in satellite, best surrogacy treatment in ahmedabad, best surrogacy hospital in satellite, best surrogacy hospital in ahmedabad, best womens hospital in satellite, best womens hospital in prahladnagar, best womens hospital in vastrapur, best womens hospital in ahmedabad, best lady gynec doctor in satellite, best lady gynec doctor in prahladnagar, best lady gynec doctor in vastrapur, best lady gynec doctor in ahmedabad.

Address: 306-307, 3rd Floor, Sahjanand Palace, Anandnagar Cross Road, Opp. Gopi Dining Hall, Prahlad Nagar, Ahmedabad, Gujarat - 380051

Phone Number: 07573966600

Email Id: snehhospitals@gmail.com

Monday to Saturday

10:00 AM to 07:00 PM

Website: www.snehhospitals.com

Facebook: https://www.facebook.com/Sneh.Multispeciality.hospital/

Twitter: https://twitter.com/hospitalsneh

Linkedin: https://www.linkedin.com/company/snehhospitals/

Google Map:

Best Womens Hospital in Prahladnagar

(Original Source: https://sites.google.com/view/bestwomenshospitalinsatellite/)

[abhijeetrlove]

IVF Services Market Slated a Massive Growth in 2024

In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperm outside the body, in vitro. The global IVF services revenue market generated $10,587 million in 2017 and is projected to reach $22,467 million by 2025, growing at a CAGR of 9.8% from 2018 to 2025.

The global IVF services market is anticipated to exhibit significant market growth during the forecast period, owing to rise in infertility rate, increase in trend of delayed pregnancies, surge in IVF success rate, and rise in disposable income worldwide. However, high cost, complications associated with IVF treatment, and low awareness level for IVF in some underdeveloped regions hinder the growth of the market. Conversely, upsurge in fertility tourism, increase in number of fertility clinics, and growth opportunities in the emerging markets make way for market development in the future.

Get Sample Pdf with Latest Market insights@ https://www.qurateresearch.com/report/sample/HnM/QBI-AMR-HnM-120661

[cool-dangerousheartcollecto-blog]

According to a recent report by KDMI, Human Chorionic Gonadotropin Market is anticipated to Boom by 2025

KD Market Insights has published a new report on Human Chorionic Gonadotropin Market analysis and forecast 2017-2025. The report comprises of Human Chorionic Gonadotropin Market size, Y-o-Y growth analysis, and market dynamics, including growth drivers, restraining factors, opportunities, and trends which are spearheading current nature and future status of the market.

The global human chorionic gonadotropin (hCG) market generated a revenue of $688 million in 2017 and is expected to reach $1,239 million by 2025, registering a CAGR of 7.6% from 2018 to 2025. hCG hormone supports the normal development of an egg in a woman’s ovary and stimulates the release of the egg during ovulation. It can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology. It is widely being used to treat infertility-related problems in women as well as increase sperm count in men. Moreover, it is used to treat cryptorchidism in young boys, a condition when the testicles have not dropped down into the scrotum normally.

Request for Sample @ https://www.kdmarketinsights.com/sample/4257

Significant surge in infertility issues among men & women and increase in prevalence of hypogonadism in geriatric population drive the growth of the global hCG market. In addition, increase in awareness toward hCG among healthcare professionals and patients fuels the market growth. However, availability of substitutes and cautions & warnings issued by FDA against the side effects of hCG hamper the growth of the market. On the contrary, rise in popularity of fertility tourism and availability of advanced IVF facilities & treatment options are expected to provide lucrative opportunities for the market in the near future.

The global hCG market is segmented based on technology, therapeutic area, end user, and region. By technology, the market is bifurcated into natural source extraction and recombinant technology. Based on therapeutic area, it is classified into female infertility treatment, oligospermic treatment, male hypogonadism, and others. Depending on end user, it is segregated into fertility clinics, research institutions, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits for Human Chorionic Gonadotropin (hCG) Market :

- The study provides an in-depth analysis of the global human chorionic gonadotropin (hCG) market along with the current trends and future estimations to elucidate the imminent investment pockets. - A quantitative analysis from 2017 to 2025 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities. - A qualitative analysis of driving factors and opportunities helps analyze the competitive scenario of the market. - Porter's Five Forces analysis is provided to interpret the bargaining power of the suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

Human Chorionic Gonadotropin (hCG) Key Market Segments :

By Technology

- Natural Source Extraction - Recombinant Technology

By Therapeutic Area

- Female Infertility Treatment - Male Hypogonadism - Oligospermic Treatment - Others

By End User

- Fertility Clinics - Research Institutions - Others

By Region

North America - U.S. - Canada - Mexico Europe - Germany - UK - France - Russia - Rest of Europe Asia-Pacific - Japan - China - India - Australia - Rest of Asia-Pacific LAMEA - Brazil - Turkey - South Africa - Saudi Arabia - Rest of LAMEA

KEY MARKET PLAYERS

- Bristol Myers Squibb Company - Merck & Co., Inc. - Ferring B.V. - Fresenius Kabi AG - Cigna - Sun Pharmaceutical Industries Ltd. - Lee BioSolutions, Inc. - Sanzyme - Scripps Laboratories - Lupin

The other players in the value chain include (profiles not included in the report):

- Kamiya Biomedical Company - Intas Pharmaceuticals - Prospec-Tany Technogene Ltd. - Cipla Limited - Biocare Medical LLC - MyBioSource - Zydus Cadila - Life Medicare & Biotech Pvt. Ltd.

Browse Full Report With TOC@ https://www.kdmarketinsights.com/product/human-chorionic-gonadotropin-market-amr

Table of Content

CHAPTER 1: INTRODUCTION

1.1. Report description 1.2. Key market benefits for stakeholders 1.3. Key market segments 1.4. Research methodology

1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope 3.2. Key findings

3.2.1. Top investment pockets

3.3. Top player positioning, 2017 3.4. Porters five forces analysis 3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. High risk of hypogonadism in geriatric population 3.5.1.2. Rise in infertility rates 3.5.1.3. Increase in awareness toward hCG among healthcare professionals and patients

3.5.2. Restraints

3.5.2.1. Availability of substitutes 3.5.2.2. Cautions & warnings issued by FDA against the side effects of hCG

3.5.3. Opportunity

3.5.3.1. Rise in popularity of fertility tourism

CHAPTER 4: HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY TECHNOLOGY

4.1. Overview

4.1.1. Market size and forecast

4.2. Natural source extraction

4.2.1. Key trends and opportunities 4.2.2. Market size and forecast, by region 4.2.3. Market analysis, by country

4.3. Recombinant technology

4.3.1. Key trends and opportunities 4.3.2. Market size and forecast, by region 4.3.3. Market analysis, by country

CHAPTER 5: HUMAN CHORIONIC GONADOTROPIN MARKET, BY THERAPEUTIC AREA

5.1. Overview

5.1.1. Market size and forecast

5.2. Female infertility treatment

5.2.1. Market size and forecast 5.2.2. Market analysis, by country

5.3. Oligospermic treatment

5.3.1. Market size and forecast 5.3.2. Market analysis, by country

5.4. Male hypogonadism

5.4.1. Market size and forecast 5.4.2. Market analysis, by country

5.5. Others

5.5.1. Market size and forecast 5.5.2. Market analysis, by country

CHAPTER 6: HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Fertility clinics

6.2.1. Market size and forecast, by region 6.2.2. Market analysis, by country

6.3. Research institutes

6.3.1. Market size and forecast, by region 6.3.2. Market analysis, by country

6.4. Others

6.4.1. Market size and forecast, by region 6.4.2. Market analysis, by country

Continue…

Check for Discount @ https://www.kdmarketinsights.com/discount/4257

About KD Market Insights

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.

Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us

KD Market Insights

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: sales@kdmarketinsights.com

Website: www.kdmarketinsights.com

[sophiajhon-blog]

Germany In Vitro Fertilization (IVF) Market Outlook and Growth Forecasted By 2026

A new market research report on the Germany In Vitro Fertilization (IVF) market has introduced by KD Market Insights. The report is dedicated to in-depth industry analysis of the Germany In Vitro Fertilization (IVF) market. The Germany In Vitro Fertilization (IVF) analysis is broken down on different segmentation levels including Market By Cycle Type, By End User. The Germany IVF market was valued at $398 million in 2018 and is estimated to reach $541 million by 2026, registering a CAGR of 3.9% during the analysis period. In vitro fertilization (IVF) is a process that includes fertilization of egg cells outside the body. It is one of the widely known infertility treatment across the clinical industry. The technique is based on assisted reproductive technology and is employed in the treatment of infertility. The process involves removing an ovum (egg or eggs) the ovaries and facilitating its fertilization with the help of a sperm in a laboratory dish. After the fertilized egg (zygote) undergoes embryo culture for up to 6 days, it is implanted in another or same woman's uterus, depending on the conditions. IVF helps achieve pregnancy when other treatments fail. It is generally not used until less expensive or invasive options have failed or been determined unlikely to work. Get Report Sample Copy @ https://www.kdmarketinsights.com/sample/5470 Subsidizing IVF treatments, delayed marriages and parenthood decisions, and increase in prevalence of infertility issues are the factors that majorly drive the growth of the IVF market in Germany. In addition, as per National Health Plan (NHP), about 50% of the treatment cost by IVF paid for three cycles is projected to boost growth of the IVF market in Germany. However, stringent government regulations and lack of availability in treatment cycles for IVF are the major restraints that hamper the growth of the market in Germany. The Germany in vitro fertilization market (IVF) is segmented based on cycle type and end user. Based on cycle type, the market is divided into fresh IVF cycles (non-donor), and thawed IVF cycles (non-donor). Based on end user, the market is classified into fertility clinics, hospitals, surgical centers, and clinical research institutes. KEY MARKET BENEFITS > The study provides an in-depth analysis of the Germany in vitro fertilization (IVF) market along with the current trends and future estimations to elucidate the imminent investment pockets. > The report presents a quantitative analysis of the market from 2018 to 2026 to enable stakeholders to capitalize on the prevailing market opportunities. > An extensive analysis of the market based on application assists in understanding the trends in the industry. > The key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry. KEY MARKET SEGMENTS Germany In Vitro Fertilization Market By Cycle Type > Fresh IVF Cycles (Non-donor) > Thawed IVF Cycles (Non-donor) By End User > Fertility Clinics > Hospitals > Surgical Centers > Clinical Research Institutes Access Complete Research Report with TOC @ https://www.kdmarketinsights.com/product/germany-in-vitro-fertilization-market-amr Table of Content Chapter 1: Introduction 1.1. Report Description 1.2. Key Benefits For Stakeholders 1.3. Key Market Segments 1.3.1. List of Key Players Profiled In The Report 1.4. Research Methodology 1.4.1. Primary Research 1.4.2. Secondary Research 1.4.3. Analyst Tools And Models Chapter 2: Executive Summary 2.1. Key Findings of The Study 2.2. Cxo Perspective Chapter 3: Market Overview 3.1. Market Definition And Scope Chapter 4: Germany In Vitro Fertilization (Ivf) Market 4.1. Overview 4.2. Germany Ivf Market By Cycle Type 4.2.1. Fresh Ivf Cycles (Non-Donor) 4.2.2. Thawed Ivf Cycles (Non-Donor) 4.3. Number of Infertility Clinics, 2018 4.4. Germany Ivf Market By End Users 4.4.1. Fertility Clinics 4.4.2. Hospitals 4.4.3. Surgical Centers 4.4.4. Clinical Research Institutes 4.5. Market Drivers 4.5.1. Drivers 4.5.1.1. Subsidizing Ivf Treatments 4.5.1.2. Delayed Marriages And Parenthood Decisions 4.5.2. Restraints 4.5.2.1. Stringent Government Regulations 4.5.2.2. Lack of Availability In Treatment Cycles For Ivf 4.5.3. Regulatory Issues, Legislations, And Authorities 4.5.4. Insurance Reimbursement Scenario 4.6. Company Profiles – Germany 4.6.1. Heidelberg University Hospital 4.6.1.1. Company Overview 4.6.2. Klinikum Stuttgart 4.6.2.1. Company Overview 4.6.3. Drk Kliniken Berlin 4.6.3.1. Company Overview 4.6.4. University Medical Center Freiburg 4.6.4.1. Company Overview 4.6.5. Praxis Fur Fertilitat 4.6.5.1. Company Overview 4.6.6. Vivaneo Deutschland Gmbh 4.6.6.1. Company Overview Continue @... Check for Discount @ https://www.kdmarketinsights.com/discount/5470 About Us: KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market. Contact Us: KD Market Insights 150 State Street, Albany, New York, USA 12207 +1 (518) 300-1215 Email: sales@kdmarketinsights.com Website: www.kdmarketinsights.com https://marketreserachtab.blogspot.com/ http://kdmarketinsights.blogspot.com/

[programsbos]

Life story of the sword of God Khaled Ibn Al - Walid

Life story of the sword of God Khaled Ibn Al - Walid

Khalid ibn al-Walid ibn al-Mughira al-Makhzoumi al-Qurashi (30 BC - 21 AH / 592--642 CE) was a companion and a Muslim military leader, nicknamed the Prophet by the sword of God. Known for his good military planning and mastery of leading Muslim armies in the wars of apostasy and conquest of Iraq and the Levant, during the reign of the successors of the Prophet Abu Bakr and Omar within several years from 632 to 636. He was not defeated in more than a hundred battles by numerically superior forces from the Byzantine Roman Empire, the Persian Sassanid Empire and their allies, as well as many other Arab tribes. Khaled is known for his decisive victories in the battles of Al-Yamamah, Alice and Al-Fard, and the tactics he used in the battles of Al Walaja and Yarmouk. Khalid ibn al-Walid played a vital role in Quraish's victory over the Muslim forces in the Battle of Uhud before his conversion to Islam. However, after converting to the Hudaybiyyah, Khalid al-Din al-Islami participated in various campaigns during the time of the Prophet, the most important of which were the Battle of Mutah and the conquest of Mecca. In 638, at the height of his military victories, he was removed by the Caliph Omar ibn al-Khattab from the command of the armies because he feared that people would be fascinated by him. Until his death and buried it.     Is: Khalid bin Walid bin Mughira bin Abdullah bin Amr bin Makhzoum bin vigilance of the time bin Ka'b bin Louay bin Ghalib bin Fahr bin Malik bin Quraish bin Kenana, known as Abu Suleiman, it was said: Abu Walid. Meets in descent with the Prophet at the time bin Kaab the sixth grandfather of the Prophet.     His father: Al-Walid ibn al-Mughayra, Sayyid Bani Makhzoum, one of the stomachs of Quraish, was so high that he was refusing to light a fire to feed people, especially in the seasons of Hajj and Okaz Souk, and one of the richest people in Mecca in his time. Because the Quraysh was covering the Ka'bah in a year, and the newborn alone wore it a year. His mother: the gate of the youngest girl Al-Harith semicircular Bani Hilal bin Amer bin Saasa of Hawazen, it meets in descent with the Prophet in the harmful Ben Nizar seventeenth grandfather of the Prophet.     Grandfather to his father: Mughira bin Abdullah Sayyid Bani Makhzoum, who was a man of the sons of Makhzoum affects honorable affiliation, and who had a lot of children, the most famous Alwaleed Abu Khalid and "fruit" who had a generosity of a guest house housing him without permission, and "Abu Hanifa" one of the four who took the parties to the robe of the Prophet on that differed Quraish when building the Kaaba, and "Abu illiteracy" nicknamed "increased knees" because it was enough companions their travel, which is Abu Umm al-Mu'minin Umm Salamah and Sahaabi migrant bin Abi illiteracy, and "Hisham," leader of the sons of Makhzoum in the war of the ungodly, which chronicled Quraish death, and did not market three Mecca to grieve him, a Abu Abu Is, and "Hashim" grandfather companion Omar bin al-Khattab to his mother.     His grandmother to his mother: Hind bint Auf bin Zuhair ibn al-Harith, which is said to be "Akram old in the land in flesh", [It is the mother of believers Maimuna bint al-Harith "Arwa bint Amis" Alkhthmia husband Hamza bin Abdul Muttalib and Asma bint Amis husband Jaafar bin Abi Talib then Abu Bakr and then Ali bin Abi Talib.     Siblings: Six brothers and nine were said between males and females, including the companions Alwaleed bin Alwaleed and Hisham bin Alwaleed, in addition to the building bin Alwaleed offered by Quraish instead of Abu Talib to surrender Muhammad, which was rejected by Abu Talib.     His tribe: the sons of Makhzoum, the belly that had the order of the dome, which was hit to collect what is equipped by the army, and the aid of horses, which is the command of the cavalry in the wars of Quraish. Makhzoum had a great impact in Quraish. Omar bin Abi Rabia and the follower Saeed bin Musayyib. According to Ashraf Quraish, Khaled was sent to the desert, to be raised by a nursing woman and growing up right in the desert. He returned to his parents at the age of five or six. During his childhood, Khaled fell ill with smallpox, but left some scars on his left cheek. Like other sons of the nobles, he learned equestrianism, but he showed great nobility and skill in the equestrian since early, and excelled on all his peers, Khalid was an excessive force also known as courage, skin and feet, and skill and agility in the hit and run. He was able to "prove" his presence in the battlefields, and showed the art of equestrian and craftsmanship in fighting what made him one of the best knights of his time His recipe Khaled was a long-time, great body and important, tends to whiteness, thick beard, very similar to Omar bin al-Khattab, so that the visually impaired were confused between them. Khaled in the era of the Prophet Muhammad Before he became Muslim Little is known about Khalid during the time of Islam in Mecca. After the migration of the Prophet from Mecca to Medina, there were many battles between Muslims and Quraish. Khalid Badr did not fight the first major battles between the two teams, in which his brother Walid was captured in the hands of Muslims. Khaled and his brother Hisham went to Fath al-Walid in Yathrib. The Battle of Khaled was one of Khalid's first battles in the conflict between the two powers, in which he took command of the Qarmatis starboard. Khaled played a vital role in favor of the Qarasheen, he was able to turn the tide of the battle, after exploiting the error of Muslim archers, when they left the mountain archers to collect loot after the superiority of Muslims at the beginning of the battle. Khaled took advantage of this mistake to wrap around Mount Archers and attack his knights at the back of the Muslim army, which turned the circle on Muslims, and turned the defeat of the Qarashians to victory. Khaled also participated in the ranks of the parties in the Battle of the Trench, and he and Amr ibn al-As took the back of the army in two hundred horsemen, for fear of being pursued by Muslims. He was also at the head of the Quraish cavalry, who wanted to convert between Muslims and Mecca in the conquest of Hudaybiyah. Islamization While Muslims were in Mecca to perform the Umrah in the year 7 AH, according to the agreement concluded in the reconciliation of Hudaybiyah, the Prophet sent to Alwaleed bin Walid, and asked him about Khalid, saying to him: «What Khalid does not know Islam, even if making his joke alone with Muslims on The polytheists were good to him, and we gave it to others. ”[31] Walid sent Khaled to a letter inviting him to Islam and to realize what he had missed. This was agreed by Khalid, who offered to Safwan bin illiteracy and then to Ikrima bin Abi ignorance to join him in his trip to Yathrib to declare Islam, but they refused. Then he presented the matter to Othman bin Talha al-Abdri, and he agreed. While they were on their way to Yathrib, they met Amr ibn al-Aas immigrant to declare his Islam, entered the three Yathrib in zero in 8 AH declaring their Islam, and then the Prophet said: "The Mecca has thrown to us the lavish liver." When he arrived in Medina, Khaled told Abu Bakr a vision he saw in his sleep as if he was in a narrow, infertile country. He went out to a vast green country. He said to him: "Your way, which Allah guided you to Islam, and the tribulation you were in from shirk." Saif Allah almasloul In 8 AH, the Prophet directed an army to fight the Ghassanids, after he objected Sharhabeel bin Amr Ghassani factor Caesar Roman Balqa Harith bin Omair Azdi Messenger of the Prophet Muhammad to the owner of Bosra, and killed. Khaled, a newcomer to Islam, joined the 3,000-strong army. The Prophet Zaid bin Haritha chose to lead the army, to be succeeded by Jaafar bin Abi Talib if killed, then Abdullah bin Rawahah that killed Jaafar, and the killing of three Muslims choose a leader among them. When the army arrived in Mu'ta, Muslims found themselves in front of an army of 200,000 fighters, half of them Roman and half of the Ghassanids. Muslims were surprised by the situation, and stayed for two nights in Maan consult them. Some suggested that they send the messenger to explain the situation to him, and wait for either the durations or the new orders. Ibn Rawaha opposed it, and persuaded Muslims to fight. The battle began, and the Muslims faced a difficult situation, killing the three leaders in a row, then the Muslims chose Khalid to lead them in the battle. The army withstood the rest of the day, and at night, Khaled Maimana moved his army to Maisara, and Maisara to Maimana. He then ordered a sect to raise dust and fuss over the army until the morning. In the morning, the Roman army and the Ghassanids were surprised by the change of faces and flags from those they faced yesterday, in addition to the fuss, they thought that durations had come to the Muslims. Then he ordered the withdrawal and the Romans feared that they would pursue them, fearing that the withdrawal would be intriguing. Khaled fought valiantly in the Battle of Mutah, and broke in his hand that day nine swords. After he returned to Yathrib, the Prophet praised him and called him the sword of God. Months later, Quraish overturned one of the terms of the peace, when Bakr ibn Mannat ibn Kenanah attacked the allies of Quraish, the sons of Khuza'a, allies of the Prophet. Then the messenger went in an army of ten thousand fighters to Mecca, and the army was divided into four sections took the command of one of them and ordered Zubair bin Awam and Saad bin worship and Khalid bin Walid on the other three, and ordered them to enter Mecca each door. They entered each of the door entrusted to him, and did not meet one of them only battalion Khalid, where his killer Ikrima bin Abi Jahl and Suhail bin Amr and Safwan bin illiteracy in the soldiers gathered to fight Muslims, and Khalid was able to win them, and killed a number of them. Then the Apostle sent him in a secret of thirty horsemen to demolish the idol of all the sons of Kenana, Vdhmha and then returned to the Prophet, he told him the Apostle asked if he had seen something, he replied, and the Prophet asked him to return because he did not destroy it. Khaled returned when he was angry and stripped his sword, and came out to him a naked black publisher, and hit her Khaled Vfqha halves and returned to the Prophet. He told him he said: "Yes that attribution, has desperate to worship your country never!". Secret Khalid bin Walid to the children of Jumaima After the conquest, the Prophet sent the Saraya to invite the tribes to Islam, and Khaled bin al-Walid sent a commander of 350 immigrants and supporters and Bani Selim in secret to "Bani Juthaima bin Amer bin Abdul Manat bin Kenana," and did not order him to fight. [45] Here was the first stalemate Khalid, where he fought, and hit them, despite the opposition of his companions, including Salem Mawla Abu Hudhayfah and Abdullah bin Omar bin al-Khattab, when the news arrived to the Prophet raised his hands to heaven and then said: "Oh God, I am healed for you Khalid ibn al-Walid". The Prophet sent Ali to the sons of Juthaima, to pay the blood of their dead. Despite this mistake, the Prophet then engaged him in the Battle of Hanin, where the Prophet made him a leader on the Bani Selim, and was seriously injured. Khaled also participated in the Battle of Tabuk under the leadership of the Prophet, and from there the Prophet sent in secret to Dumat al-Jandal, and entered it and captured the owner Akidar bin Abdul Malik, who favored the Prophet on the tribute, and demolished their idol "Wad." In 10 AH, the Prophet Khalid bin Al-Walid sent in the month of Rabi I in secret from four hundred fighters to the sons of Harith bin Kaab Najran, and ordered him to invite them to Islam before he fights them three, if they responded to him accept them and reside in them and teach them their religion, although they do not fight them . The sons of al-Harith bin Ka'b answered the call and converted to Islam, and Khaled established them teaching them Islam. Then Khalid wrote to the Prophet so, he ordered him to reside in them teach them, and then to accept with them their delegation, they sent him to declare their Islam. After the death of the Prophet, most of the Arab tribes except the people of Mecca, Taif, and tribes neighboring Mecca, Medina and Taif, overtook Sultan Abu Bakr, the new Muslim caliph. The reasons for the objection differed, some of them apostatized from the Islamic religion, and some of them remained on the religion of Islam with their refusal to pay the zakat obligation, and some of them to circumvent the claim of prophecy in the Arab tribes. Zakat blockers from the tribes of Abs, Zebian and Dafthan exploited the departure of Osama bin Zaid, who had been recommended by the Prophet before his death, and tried to attack the city. After the caliph was able to repel the attack, and sent from chasing remnants of the defeated, Abu Bakr held eleven brigades to fight apostates and zakat supporters throughout the Arabian Peninsula. Abu Bakr ordered Khalid ibn al-Walid on one of those armies of 4,000 fighters, and directed him to subdue Tei then fight the proponent of prophecy Taliha bin Khuwaylid and his tribe Bani Asad, then go to subdue Bani Tamim. However, before the army moved, Uday ibn Hatim al-Ta'i arrived with zakat funds, to join Khalid's army. The tribes of Asad, Fazara, Saleem, remnants of Abs, Zebian, and Bakr gathered around Taliha ibn Khuwaylid, who claimed prophecy. Khaled went to his army, clashed with them in Bzkhah, defeated them and fled Taliha to Syria. Khalid then ordered to chase the remnants of the defeated, then ordered the burning of prisoners and fire them, and sent their bosses handcuffed to the Caliph to see what he is doing to them, to inflict those who remained on their religion of harm, and to be a deterrent to those who will meet him afterwards Zul bin Haritha killed her mother or cinnamon in his secret to Bani Fazara, for inciting her people to fight Muslims. Khaled fought them in a big battle in Zafar, defeated them and killed Umm Zamel Khaled then went to Bani Tamim with his army. The children of Tamim were not on the same position, some of them the stomachs of giving zakat and follow the successor of the Messenger of Allah, and some of them saw the opposite, and a third team remained confused. When Khaled al-Battah's army arrived, the house of the sons of Jerobo, he found no one. It was their master Malik bin Nuwaira who were puzzled in their order, and had ordered his people to disperse. Khaled broadcast the companies, and ordered them to bring him to all who did not answer the preacher of Islam, even if he refuses to kill him. Abu Bakr had advised them to give permission if they went down to a house. Then, the soldier came to Malik bin Nuwaira in a group of his people, the secrecy of them differed, witnessed Abu Qatada Ansari that they set up prayer, and others said: they did not give permission and did not pray. Khalid ordered the killing of Ibn Nuwaira, and the narrators differed in the reason for the killing of Khalid Malik, some of them said that the prisoners were killed because the night was cold, has ordered Khaled to warm the prisoners, and meant in the language of Kinana killing, the guards killed them. Some of them said that it took place between Khalid and the owner of a dialogue from which Khalid concluded that the owner denies zakat, killing him so. On the night of Malik's death, he married Umm Tamim, Laila bint al-Minhal, Malik's wife, which was denied by many companions. The companions in the city denounced Khaled's action, and Abu Bakr sent Khaled's request. Omar ibn al-Khattab was angered by the act of Khalid, so he asked the caliph to isolate the latter, but Abu Bakr refused to do so, saying: "I was not Ashim sword God blessed the unbelievers." Abu Bakr violently immortalized his action, and then spent it to his army, and Woody owner and the response of the captivity of the sons of Jerobo. Musailma bin Habib claimed prophecy, and was able to gather around forty thousand of his people Bani Hanifa and others, who acknowledged his prophecy. It was in the testimony of `` the men of Ben Enfwa, '' which the Prophet had sent with the delegation of Bani Hanifa, when they came to declare their Islam in the year of delegations to teach them religion, that Muhammad had shared him in the prophecy, the greatest support for him in his claim, which increased the risk of sedition on Muslims. Therefore, Abu Bakr directed him a brigade led by Ikrima bin Abi ignorance, and then Ardvh another brigade led by Sharhabeel bin Hassan. Akrama hastened his decision to confront the army of Musaylama alone before the army of Sharhabeel bin Hasna realized it, which exposed him to a terrible defeat. When Sharhabeel arrived in his army, he realized the difficulty of the situation, so he sent the caliph to tell him what he was. By then, Khaled had finished the order of Bani Tamim. When Khaled arrived in his army to Al-Yamamah, he realized his army was secret from the sons of Hanifa.He ordered them to be killed and their boss kept a famine of Benmararah.He might save him from his benefit, and tied him with iron in his tent, and made him his wife, Umm Tamim. Musailma descended with his army in Aqraba on the outskirts of Yamama. Then he met the Jamaan, and was initially dominant for the children of Hanifa, retreated Muslims until they entered Fustat Khaled, and almost to Tbshwa Um Tamim, if not Agarha famine bin bitterness, because of the good treatment. At that time, the diet revolted in the hearts of Muslims, and immigrants and supporters showed tournaments that turned the tide of battle in their favor. The Muslims realized that if they did not rush to win them, the siege could be prolonged. Hanifa. Since then, the park has been called the "Garden of Death." After the battle ended, Khaled moved with his army to open Al-Yamamah's forts, and Khaled had documented a famine for his rent to Umm Tamim. A famine had been sent to the forts where only women, children, elders and those who could not fight could wear armor. He persuaded Khaled's famine that the forts were full of men.He looked at his army and was exhausted by the wars.He was killed so much that the death of Muslims on the day of the Yamamah was estimated at 200,000, of whom 360 were immigrants and supporters.Khalid saw that he would reconcile them with Muslims keeping half the captivity and spoils. Then a famine asked him to go and offer his people the matter, and then returned claiming that they did not accept the offer, and lowered Khaled to the quarter. When the Muslims entered the forts, Muslims found only women, children and the infirm, Khalid's anger to deceive him, but he found courage of famine, he was able to keep them from the rest of his people, and authorized reconciliation. After the victory of Khaled, he asked a famine to marry his daughter, and he answered a famine. This caused the anger of the Caliph and the great companions, because he did not choose the right time. Abu Bakr was sent to Khalid, and he violated him more than he did on the day of his marriage to Umm Tamim. After Al-Yamamah, Khaled's mission ended in the wars of apostasy, so he took him home in one of the Yamamah valleys where he lived with his wives.

To complete the rest of the life story of Khaled Ibn Al Waleed click here

Islamic era from Blogger https://ift.tt/2LkQwOL via IFTTT

[aditi-us]

Global Gene Therapy Market is Expected to Thrive at a CAGR of 33.3% Forecast period 2017-2023

A Comprehensive research study conducted by KD Market Insights on "Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and Applications (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Other Diseases) - Global Opportunity Analysis and Industry Forecast, 2017-2023" report offers extensive and highly detailed historical, current and future market trends in the global and regional/market. The Gene Therapy Market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments. The Global Gene Therapy Market was valued at $584 million in 2016, and is estimated to reach $4,402 million by 2023, registering a CAGR of 33.3% from 2017 to 2023. Gene therapy is a technique that involves the delivery of nucleic acid polymers into a patient’s cells as a drug to treat diseases. It fixes a genetic problem at its source. The process involves modifying the protein either to change the genetic expression or to correct a mutation. The emergence of this technology meets the rise in needs for better diagnostics and targeted therapy tools. For instance, genetic engineering can be used to modify physical appearance, metabolism, physical capabilities, and mental abilities such as memory and intelligence. In addition, it is also used for infertility treatment. Gene therapy offers a ray of hope for patients, who either have no treatment options or show no benefits with drugs currently available. The ongoing success has strongly supported upcoming researches and has carved ways for enhancement of gene therapy. Request for Sample @ https://www.kdmarketinsights.com/sample/3544 The gene therapy market is a widely expanding field in the pharmaceutical industry with new opportunities. This has piqued the interests of venture capitalists to explore this market and its commercial potential. Major factors that drive the growth of this market include high demands for DNA vaccines to treat genetic diseases, targeted drug delivery, and high incidence of genetic disorders. However, the stringent regulatory approval process for gene therapy and the high costs of gene therapy drugs are expected to hinder the growth of the market. The global gene therapy market is segmented based on vector type, gene type, application, and geography. Based on vector type, it is categorized into viral vector and non-viral vector. Viral vector is further segmented into retroviruses, lentiviruses, adenoviruses, adeno associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others. Non-viral vector is further categorized into naked/plasmid vectors, gene gun, electroporation, lipofection, and others. Based on gene type, the market is classified into antigen, cytokine, tumor suppressor, suicide, deficiency, growth factors, receptors, and others. Based on application, the market is divided into oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and other diseases. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. KEY MARKET BENEFITS - This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities. - The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry. - In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning. - The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market. KEY MARKET SEGMENTS By Vector Type - Viral vector - - Retroviruses - - Lentiviruses - - Adenoviruses - - Adeno Associated Virus - - Herpes Simplex Virus - - Poxvirus - - Vaccinia Virus - - Others - Non-viral vector - - Naked/Plasmid Vectors - - Gene Gun - - Electroporation - - Lipofection - - Others By Gene Type - Antigen - Cytokine - Tumor Suppressor - Suicide - Deficiency - Growth factors - Receptors - Others By Application - Oncological Disorders - Rare Diseases - Cardiovascular Diseases - Neurological Disorders - Infectious disease - Other Diseases By Region - North America - - U.S. - - Canada - - Mexico - Europe - - Germany - - UK - - France - - Spain - - Italy - - Rest of Europe - Asia-Pacific - - Japan - - China - - India - - South Korea - - Rest of Asia-Pacific - LAMEA - - Brazil - - Republic of South Africa - - Rest of LAMEA KEY PLAYERS PROFILED - Novartis - Kite Pharma, Inc. - GlaxoSmithKline PLC - Spark Therapeutics Inc. - Bluebird bio Inc. - Genethon - Transgene SA - Applied Genetic Technologies Corporation - Oxford BioMedica - NewLink Genetics Corp. Browse Full Report with TOC @ https://www.kdmarketinsights.com/product/gene-therapy-market-amr Table of Contents: CHAPTER 1 INTRODUCTION 1.1. Report description 1.2. Key benefits 1.3. Key market segments 1.4. Research methodology 1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools and models CHAPTER 2: EXECUTIVE SUMMARY 2.1. CXO perspective CHAPTER 3: MARKET OVERVIEW 3.1. Market definition and scope 3.2. Key findings 3.2.1. Top investment pockets 3.2.2. Top winning strategies 3.2.2.1. Top winning strategies, by year, 2015-2017* 3.2.2.2. Top winning strategies, by development, 2015-2017* (%) 3.2.2.3. Top winning strategies, by company, 2015-2017* 3.3. Top player positioning, 2016 3.4. Porters five forces analysis 3.5. Market dynamics 3.5.1. Drivers 3.5.1.1. High investment for R&D activities pertaining to gene therapy 3.5.1.2. Increase in prevalence of cancer 3.5.1.3. Growth in awareness regarding gene therapy 3.5.2. Restraints 3.5.2.1. High cost associated with gene therapies 3.5.2.2. Unwanted immune responses 3.5.3. Opportunity 3.5.3.1. Untapped potential for emerging markets CHAPTER 4: GENE THERAPY MARKET, BY VECTOR TYPE 4.1. Overview 4.1.1. Market size and forecast 4.2. Viral vectors 4.2.1. Key market trends 4.2.2. Key growth factors and opportunities 4.2.3. Market size and forecast 4.2.4. Market Analysis by country 4.2.5. Adenovirus 4.2.6. Lentivirus 4.2.7. Retrovirus 4.2.8. Adeno-associated virus 4.2.9. Herpes simplex virus 4.2.10. Poxvirus 4.2.11. Vaccinia virus 4.2.12. Others 4.3. Nonviral techniques 4.3.1. Key market trends 4.3.2. Key growth factors and opportunities 4.3.3. Market size and forecast 4.3.4. Market Analysis by country 4.3.5. Naked plasmid vector 4.3.6. Gene gun 4.3.7. Electroporation 4.3.8. Lipofection 4.3.9. Others CHAPTER 5: GENE THERAPY MARKET, BY GENE TYPE 5.1. Overview 5.1.1. Market size and forecast 5.2. Antigen 5.2.1. Market size and forecast 5.2.2. Market size and forecast by country 5.3. Cytokine 5.3.1. Market size and forecast 5.3.2. Market Analysis, by country 5.4. Tumor suppressor 5.4.1. Market size and forecast 5.4.2. Market Analysis, by country 5.5. Suicide 5.5.1. Market size and forecast 5.5.2. Market Analysis, by country Continue… Check for Discount @ https://www.kdmarketinsights.com/discount/3544 About Us: KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights. Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market. Contact Us: KD Market Insights 150 State Street, Albany, New York, USA 12207 +1 (518) 300-1215 Email: sales@kdmarketinsights.com Website: www.kdmarketinsights.com  

[3ezentrum3-blog]

Treatment of Male Factor Infertility

Treatment of male factor fruitlessness goes for accomplishing pregnancy in the female accomplice, keeping away from hereditary transmission of infection to youngsters and administer to fundamental restorative issue in the male accomplice. Treatment depends on history, precise semen examination and hereditary and hormonal tests if showed. One critical reality is that advanced innovation takes into account accomplishing pregnancy with not very many sperm whether discharged or carefully reaped from the testicles. This shows once sperm are accessible, the most critical factor managing achievement is female factor, specifically ovarian hold the number and nature of eggs staying in the ovary. Ovarian save is assessed in light of age, female hormone investigation and pelvic ultrasound to imagine the ovaries. Variables identified with egg hold should manage decision of treatment for male factor barrenness.

Anticipation and fruitfulness safeguarding in men

Men with no male factor barrenness however in danger of lessened or loss of ripeness because of growth treatment with chemotherapy, preceding bone marrow transplantation or hereditary ailment ought to consider solidifying one or different sperm tests for later utilize. This is a straightforward and generally accessible measure

Introductory measures

Administration of way of life factors e.g smoking end, keeping away from certain medicine and evading natural introduction if conceivable. This is trailed by rehash semen examination in around 2 months.

Low sperm tally

Tallies at or over 10 million motile sperm/mL can be utilized for intrauterine insemination-IUI. Getting ready of sperm preceding IUI concentrates them and enhance their motility. This is generally joined with incitement of the ovaries to enhance the achievement rate

Checks underneath 10 million moving sperm/mL are better utilized for IVF

Sperm tests underneath 2 million sperm/mL are accomplish better pregnancy rates if utilized for IVF with ICSI.

For low sperm tallies its judicious to solidify maybe a couple tests as move down, in the event that sperm generation stops totally.

On the off chance that no sperm were found in the discharge, sperm can be recovered specifically from the testicles TESE or the epididymis (the tube that pass on sperm from the testicles)- MESA. In the event that sperm were discovered, they are utilized for ICSI.

Obstructive azospermia

In men with sperm generation however with deterrent of the course of sperm from the testicles to outside, medical procedure can sidestep the obstacle. An option is to gather sperm specifically from the testicles TESE or the epididymis-MESA

Non-obstructive azospermia

In men with no sperm generation, once in a while little regions of the testicles still create some sperm yet they are not discharged. Sperm can be recovered specifically from the testicles TESE. The achievement rates of recovering sperm is around 70%. Sperm are utilized for ICSI and the rest if any are solidified for later utilize.

Low sperm motility

On the off chance that the extent of currently moving sperm is under half, two components are tended to. Contamination in the semen is dealt with utilizing anti-toxins. Hostile to sperm antibodies at first treated with sperm washing took after by IUI. In the event that this comes up short, against sperm antibodies can be adequately overseen utilizing ICSI.

Low ordinary morphology

The state of the sperm has critical impact on its capacity to prepare the egg. On the off chance that the extent of morphologically ordinary sperm is industriously low <4% utilizing strict criteria, IVF with ICSI is regularly considered.

Hyperprolactinemia

High prolactin hormone can lessen sperm generation. High prolactin is adequately treated utilizing oral medicines that can decrease sperm creation and reestablish spermatogenesis.

Retrograde discharge

This implies sperm are discharged once more into the bladder. This can occur in men with diabetes or harm to pelvic nerves. This is normally overseen by gathering sperm from pee after discharge. Sperm are solidified for later use with IUI or ICSI.

Thought for Genetic elements

Men with basic hereditary issues as cystic fibrosis, Kleinefelter disorder, Y chromosome microdeletion ought to be advised that 1. There is a danger of transmission of these hereditary deformities to their youngsters 2. Hereditary testing of the fetuses can once in a while keep this transmission. The method is called pre-implantation hereditary analysis PGD. A cell or couple of cells of every developing life for a particular hereditary issue. Just ordinary fetuses are utilized to acieve pregnancy.

Treatment strategies for problematic viability

1. Varicocele repair. Varicoceles are gathering of enlarged veins around the testicles. Little varicoceles recognized on ultrasound just ought not be repaired by any means. Vast varicoceles palpated by the doctor can be considered for careful repair. Confirmation, anyway in not decisive that tying varicoceles increment the possibility for pregnancy in the female accomplice.

2. Solutions. With not very many special cases, utilizing oral solutions as tamoxifen, clomid or anastrozole to enhance sperm creation isn't viable in treating male factor and there is no confirmation that their utilization builds the possibility for pregnancy in female accomplice. Testosterone treatment does not enhance and may even stifle sperm creation

Amr Azim is a board confirmed conceptive endocrinologist and ripeness expert with New York City IVF and creator of numerous logical distribution in the zone of fruitfulness treatment and richness conservation. I have practical experience in basic and complex ripeness issues including richness directing and testing, male factor barrenness, PCOS, endometriosis, IUI, IVF and ICSI.

I am exceptionally enthusiastic about helping ladies, men and youngsters determined to have tumor and different maladies comprehend the effect of ailment and its treatment on future fruitfulness and help them in imagining natural kids. I compose routinely at http://nycivf.org and http://preservationoffertility.org

Article Source: http://EzineArticles.com/master/Amr_Azim/693030

Article Source: http://EzineArticles.com/5122306

[qfnunet]

Good news for infertile couples – IVF treatment in India

In Vitro Fertilization (IVF) treatment service in India will reach $775.9 million by 2022 which translates to a CAGR of 16.6 percent growth in 6 years from 2016 to 2022, according to a new report of Allied Market Research (AMR). In India, the IVF service market is rapidly growing due to the rise in

[wenickjones]

IVF Services Market Exhibits Stunning Growth Potentials | Generate Massive Revenue till 2026

Facto Market Insights (FMI), added a title on “IVF Services Market – 2020-2026” to its collection of market research reports. This market research report provides detailed analysis of market drivers, challenges, opportunity analysis, and trends, along with various key insights. In addition to this, the report on global IVF services market demonstrates the important aspects that are expected to intensify the growth of the global market over the upcoming years. The study also includes the analysis of the market size and forecast for the different segments &geographies covering the impact analysis of ongoing COVID-19 disease situation.

Get Free Sample Report at https://www.factomarketinsights.com/sample/283

The report on global IVF services market covers the key market growth indicators, covering the value and supply chain analysis, year-on-year (Y-o-Y) growth and compounded annual growth rate (CAGR), in the Facto Market Insights (FMI) research report along with top macroeconomic indicators. The study is way beneficial for the investors, manufacturers, suppliers, stakeholders, and distributors, because it can help them to understand the strategies of the market and also, they can withdraw information &statistics presented in market research report.

Impact Analysis of Coronavirus Disease (COVID-19)

The research report covers the impact analysis of COVID-19 pandemic on the global IVF services market, covering information about each region & countries in order to identify the issues raised by the pandemic over various industries. The outbreak of coronavirus or COVID-19 (formerly 2020-nCoV) was noted in December 2019, which has been imposed as a medical emergency across the globe. More than 213 countries and territories have reported cases of coronavirus till date. On 11th March 2020, the World Health Organization (WHO) declared the COVID-19 a pandemic officially. Countries including U.S., India, Italy, Germany, Spain, France, Brazil, and such other countries have a large number of COVID-19 patients, due to which the countries went under lockdown conditions in the past. Thus, with the ongoing situation of lockdown, many industries have been adversely impacted, and it is expected that the economy of such nations are going to suffer a massive loss over the upcoming years, and also the global economy is anticipated to slip into a recession, which is considered to hamper the growth of the overall market.

For Full Report with TOC Visit at https://www.factomarketinsights.com/report/283/ivf-services-market-amr

Segment Information  

The market for global IVF services market is segmented as Product Type, Form Type, Drug Type, End User and Region.

KEY MARKET SEGMENTS By Cycle Type • Fresh IVF Cycles (Non-Donor) • Thawed IVF Cycles (Non-Donor) • Donor Egg IVF Cycles

By End User • Fertility Clinics • Hospitals • Surgical centers • Clinical research institutes

Regional Representation

The market for IVF services is segregated on the basis of regional basis into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The breakdown of the region into countries is covered in the study. The study also includes the estimations about market growth at the regional and country levels. Further, the regions are fragmented into the country and regional groupings:

- North America (U.S. & Canada)

- Europe (Germany, United Kingdom, France, Italy, Spain, Russia and Rest of Europe)

- Asia Pacific (China, India, Japan, South Korea, Indonesia, Taiwan, Australia, New Zealand and Rest of Asia Pacific)

- Latin America (Brazil, Mexico and Rest of Latin America)

- Middle East & Africa (GCC, North Africa, South Africa and Rest of Middle East & Africa)

Competitive Landscape:

The report profiles various major & prominent key market players in the global IVF services market including:-

Ambroise Paré Group • amedes MVZ Cologne GmbH • AMP Center St Roch • AVA Clinic Scanfert • Bangkok IVF center • Bangkok IVF center (Bangkok Hospital) • Betamedics • Biofertility Center • Bloom Fertility and Healthcare • Bloom Fertility Center • Bourn Hall Fertility Center • Bourn Hall International • Cardone Reproductive Medicine and Infertility, LLC • Center for Advanced Reproductive Medicine and Infertility • CHA Fertility Center • Chelsea and Westminster Hospital (Assisted Conception Unit) • Cloudnine Fertility • Conceptions Reproductive Associates of Colorado • Cyprus IVF Centre • Dansk Fertilitetsklinik • EUVITRO S.L.U. • Fakih IVF Fertility Center • Fertility and Gynecology Center Monterey Bay IVF • Fertility Associates • Fertility Center Berlin • Fertility Center of San Antoni • Fertility First • FIV Marbella • Fivet Centers Prof. Zech • Flinders Reproductive Medicine Pty Ltd • Genea Oxford Fertility Limited • Heidelberg University Hospital • Houston Fertility Center • International Centre for Reproductive Medicine, ICRM • IVF Canada • IVF NAMBA Clinic • IVF Panama Center for Reproduction Punta Pacífica • IVF Spain • IVI Panama • Ivinsemer • KL Fertility & Gynaecology Centre • Lifesure Fertility and Gynaecology centre • LIV Fertility Center • Manipal Fertility • Maria Fertility Hospital • MD Medical Group • Medfem Fertility Clinic • Monash IVF Wesley Hospital Auchenflower • Morpheus Life Sciences Pvt. Ltd. • New hope fertility center • Oak Medical Group/Oak Clinic • OVA IVF Clinic Zurich • Procrea Fertility • RAPRUI Srl • Repromed • SAFE Fertility Center • Sanno Hospital • Servy Massey Fertility Institute • Shanghai Ji Ai Genetics & IVF Institute • Shanghai United Family Hospital • Sher Institute for Reproductive Medicine (SIRM) • Southend Fertility and IVF • StorkKlinik (Stork IVF Clinic) • The ARC-STER Center • The Bridge Centre • The Cape Fertility Clinic • The Hugh Wynter Fertility Management Unit • The Lister Fertility Clinic • The Montreal Fertility Center • Thomson Medical Pte. Ltd. • Trianglen Fertility Clinic • TRIO Fertility • Virtus Health • Vitanova • VivaNeo - Medical Center Kinderwens • Wunschkinder

For any Inquiry before buying this report visit at https://www.factomarketinsights.com/enquiry/283

About Us:

Facto Market Insights is one of the leading providers of market intelligence products and services. We offer reports on over 10+ industries and update our collection daily which helps our clients to access database of expert market insights on global industries, companies, products, and trends.

Our in-house research experts have a wealth of knowledge in their respective domains. With Facto Market Research, you always have the choice of getting customized report free of cost (upto 10%). Our support team will help you customize the report and scope as per your business needs. This ensures that you are making the right purchase decision.

Our clients list includes various Fortune 500 companies and leading advisory firms.

Contact Us:

Facto Market Insights

90 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email:info@factomarketinsights.com

Website: www.factomarketinsights.com

[abhijeetrlove]

Donor Egg IVF Services Market Market 2019 Analysis, Industry Growth, Size, Forecast 2025

In vitro fertilization is an assisted reproductive technology (ART), which involves retrieving eggs from a woman’s ovaries and fertilizing them with sperms outside the body, that is, in vitro. The donor egg IVF services market for the customized regions generated $1,668 million in 2017 and is projected to reach $3,290 million by 2025, growing at a CAGR of 8.8% from 2018 to 2025. The market is anticipated to exhibit significant growth during the forecast period, owing to rise in infertility rate, increase in the trend of delayed pregnancies, surge in the IVF success rate, and rise in disposable incomes in the Asia-Pacific region. However, complications associated with IVF treatment and low awareness level for IVF in some underdeveloped regions hinder the growth of the market. Conversely, upsurge in fertility tourism, increase in number of fertility clinics, and growth opportunities in the emerging markets are expected to make way for market development during the forecast period.

Get Sample Pdf with Latest Market insights@ https://www.qurateresearch.com/report/sample/HnM/QBI-AMR-HnM-120573

The global donor egg IVF services market is segmented based on cycle type, end user, and country. Based on cycle type, the market is divided into fresh donor egg IVF cycle and frozen donor egg IVF cycle. According to end user, the market is classified as fertility clinic, hospital, surgical center, and clinical research institute. As per country, the market is studied across Australia, New Zealand, Thailand, Malaysia, Rest of Asia-Pacific, South Africa, Canada, and Ireland.

[cool-dangerousheartcollecto-blog]

In Vitro Fertilization (IVF) Services Market Grow with New Opportunities & Developments by 2023

KD Market Insights has published a new report on global In Vitro Fertilization (IVF) Services Market analysis and forecast 2017-2023. The report comprises of In Vitro Fertilization (IVF) Services Market size, Y-o-Y growth analysis, and market dynamics, including growth drivers, restraining factors, opportunities, and trends which are spearheading current nature and future status of the market.

In vitro fertilization (IVF) is the process of artificial fertilization which happens outside the women’s body. The egg of the women is surgical removed and are fertilized by a sperm in a laboratory. In vitro fertilization is mainly used by women having a problem in conceiving. However, IVF does not always result in pregnancy and success rate varies from individual to individual. IVF procedures have emerged as a preferable choice for the fertility treatments in clinical industry. The market is poised to witness a remarkable growth, primarily due to the related technological advancements such as pre-implantation genetic diagnosis (PGD) and three-parent IVF procedures.

Request for Sample @ https://www.kdmarketinsights.com/sample/5207

The global IVF market generated a revenue of $9,876 million in 2016 and is expected to reach $19.676 million by 2023, at a CAGR of 10.5% during the analysis period, 2017-2023. The growth of the market is attributed to the reduced conceiving rates, delayed pregnancy, changing lifestyle conditions and fertility disorders are the major factors that drive the market growth. Other factors such as favorable reimbursement scenario and delayed parenthood opted by couples due to professional and financial constraints will also help in the growth of the market. On the other hand, barriers such as ethical concerns in particular countries with respect to IVF, high cost of the IVF procedures followed by low awareness, especially in under-developed economies such as Nigeria are likely to restrain the market growth.

Rising initiatives towards commercialization of cost-efficient treatments and emerging medical tourism, mainly in developing nations would offer lucrative growth opportunities for IVF service providers in future. Further, the growing clinical research initiatives for the development of novel IVF technologies would provide a platform for growth of the global IVF market.

The world IVF market is segmented on the basis of cycle type, end users and geography. Based on cycle types, the market is segmented into fresh cycle (non-donor), thawed IVF cycle (non-donor) and donor egg IVF cycles. Fresh cycle (non-donor) is both the highest revenue generating segment as well as the highest growing segment as it is the most commonly adopted method in a IVF process due to high success rate. Similarly, by end users, the market is further segmented into fertility clinics, hospitals, surgical centers and clinical research institutes. In terms of geography, the market is segmented into North America, Europe, Asia-Pacific (APAC) and Latin America, Middle East and Africa (LAMEA).

KEY BENEFITS FOR STAKEHOLDERS:

- The report provides an in-depth analysis of the IVF market across major countries with a cross sectional analysis of the number of IVF cycles performed, and total revenue generated during the forecast period. - The report helps in understanding the strategies adopted by various IVF clinics and hospitals, in order to gain a higher market share in the global IVF market. - Region-wise and country-wise share in the global IVF market is comprehensively analyzed in the report. - The projections in the report are made by analyzing the current market trends and highlighting the market potential for the period of 2017-2023, in terms of value and volume. - The study provides an in-depth analysis of the world IVF Services market with current trends and future estimations to elucidate the imminent investment pockets.

KEY MARKET SEGMENTS:

Market by End Users

- Fertility Clinics - Hospitals - Surgical centers - Clinical research institutes

Market, By Geography

North America - United States - Canada - Mexico Europe - United Kingdom - Germany - France - Italy - Spain - Denmark - Russia - Others Europe Asia-Pacific - China - India - Japan - Australia - New Zealand - Korea - Thailand - Others APAC LAMEA - Latin America - Middle East - Africa

Browse Full Report With TOC@ https://www.kdmarketinsights.com/product/in-vitro-fertilization-ivf-services-market-amr

Table of Content

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION 1.2. KEY BENEFITS 1.3. KEY MARKET SEGMENTS 1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research 1.4.2. Primary research 1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 WORLD IN VITRO FERTILIZATION (IVF) MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE 3.2. IVF PRICING TRENDS BY COUNTRY 3.3. IVF CYCLES BY COUNTRY 3.4. GLOBAL IVF MARKET BY END USERS

3.4.1. Fertility clinics 3.4.2. Hospitals 3.4.3. Surgical centers 3.4.4. Clinical research institutes

3.5. GLOBAL IVF MARKET BY CYCLE TYPE

3.5.1. Fresh IVF cycles (non-donor) 3.5.2. Thawed IVF cycles (non-donor) 3.5.3. Donor egg IVF cycles

3.6. MARKET DYNAMICS

3.6.1. Drivers

3.6.1.1. Delayed pregnancies 3.6.1.2. Rise in global infertility rates 3.6.1.3. Emergence of new fertility tourism destinations

3.6.2. Restraints

3.6.2.1. High Cost involved in the treatment 3.6.2.2. Low level of awareness in developing economies 3.6.2.3. Inadequate reimbursements policies for IVF treatments 3.6.2.4. Ethical Considerations

3.6.3. Opportunities

3.6.3.1. relaxing the legal considerations on ivf treatments 3.6.3.2. New technology development and treatment options 3.6.3.3. Three parent IVF

3.7. KEY FINDINGS

CHAPTER 4 NORTH AMERICA IVF MARKET

4.1. UNITED STATES IVF MARKET, (REVENUE AND NUMBER OF CYCLES)

4.1.1. Number of Infertility Clinics, 2016 4.1.2. United States IVF Market by End Users

4.1.2.1. Fertility clinics 4.1.2.2. Hospitals 4.1.2.3. Surgical centers 4.1.2.4. Clinical research institutes

4.1.3. United States IVF market by cycle type

4.1.3.1. Fresh IVF cycles (non-donor) 4.1.3.2. Thawed IVF cycles (non-donor) 4.1.3.3. Donor egg IVF cycles

4.1.4. Drivers

4.1.4.1. Increasing popularity of IVF in United States 4.1.4.2. Increased rate of infertility and practices of embryo banking cycles

4.1.5. Restraints

4.1.5.1. High cost of IVF treatment in United Sates 4.1.5.2. Restrictions on 3-parent IVF treatments 4.1.5.3. Scattered Reimbursements

4.1.6. Regulatory Issues, Legislations and Authorities 4.1.7. Insurance Reimbursement Scenario 4.1.8. Company Profile

4.1.8.1. Fertility and Gynecology Center Monterey Bay IVF 4.1.8.2. Conceptions Reproductive Associates 4.1.8.3. Servy Massey Fertility Institute 4.1.8.4. Sher Institute for Reproductive Medicine (SIRM) 4.1.8.5. Cardone Reproductive Medicine & Infertility 4.1.8.6. Fertility Center of San Antonio 4.1.8.7. Houston Fertility Center 4.1.8.8. New hope fertility center 4.1.8.9. Reproductive Medicine Associates Of New Jersey

4.2. CANADA IVF MARKET (REVENUE AND NUMBER OF CYCLES)

4.2.1. Number of infertility centers 4.2.2. Canada IVF Market by End users

4.2.2.1. Fertility clinics 4.2.2.2. Hospitals 4.2.2.3. Surgical centers 4.2.2.4. Clinical research institutes

4.2.3. Canada IVF market by cycle type

4.2.3.1. Fresh IVF cycles (non-donor) 4.2.3.2. Thawed IVF cycles (non-donor) 4.2.3.3. Donor egg IVF cycles

4.2.4. Market Dynamics

4.2.4.1. Drivers

4.2.4.1.1. Commercialization of IVF booster in Canada

4.2.4.2. Restraints

4.2.4.2.1. High cost of IVF in Canada

4.2.5. Regulatory Issues, Legislations and Authorities 4.2.6. Insurance Reimbursement Scenario 4.2.7. Company Profile

4.2.7.1. Toronto Centre for Advanced Reproductive Technology Ltd. 4.2.7.2. Fertility Treatment Center 4.2.7.3. Montreal Fertility Center

4.3. MEXICO IVF MARKET (REVENUE AND NUMBER OF CYCLES)

4.3.1. Number of infertility centers 4.3.2. Mexico IVF Market by End Users

4.3.2.1. Fertility clinics 4.3.2.2. Hospitals 4.3.2.3. Surgical centers 4.3.2.4. Clinical research institutes

4.3.3. Mexico IVF market by cycle type

4.3.3.1. Fresh IVF cycles (non-donor) 4.3.3.2. Thawed IVF cycles (non-donor) 4.3.3.3. Donor egg IVF cycles

4.3.4. Market Dynamics

4.3.4.1. Drivers

4.3.4.1.1. Fertility tourism 4.3.4.1.2. Comparatively low cost of IVF

4.3.4.2. Restraints

4.3.4.2.1. Language Barriers

4.3.5. Regulatory Issues, Legislations and Authorities 4.3.6. Insurance Reimbursement Scenario 4.3.7. Company Profile

4.3.7.1. Liv Fertility Center In Puerto Vallarta 4.3.7.2. BFC Biofertility Center

Continue…

Check for Discount @ https://www.kdmarketinsights.com/discount/5207

About KD Market Insights

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.

Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us

KD Market Insights

150 State Street, Albany,

New York, USA 12207

+1 (518) 300-1215

Email: sales@kdmarketinsights.com

Website: www.kdmarketinsights.com

Read More News: http://kdmarketinsights.blogspot.com/

https://marketreserachtab.blogspot.com/